Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Store reconstituted solution at 28C
Visit our library of clinical research that supports our approach to enhancing your health and overall quality of life.
Oct 2018;38(5):773-780
The "minimal initial benefit" group (approximately 5-10% of users) reported limited improvements during treatment making discontinuation effects irrelevant, typically explained by inadequate product quality with degraded or low-concentration GHK-Cu, inappropriate application technique reducing absorption, unrealistic expectations exceeding what any topical can achieve, severe underlying pathology requiring medical intervention beyond cosmetic peptides, or individual non-responsiveness to copper peptide treatment for genetic or physiological reasons
US$ 28.30
US$ 20.22
US$ 25.27
US$ 26.17
US$ 29.18
